论文部分内容阅读
患者罗某,男性,56岁,住院号35495。活检证实为鼻咽低分化鳞癌,T_2N_1M_0属Ⅱ期,于74年11月7日起用~(60)钴作常规足量放疗。41个月后,再次活检证实为鼻咽原灶复发,并于78年7月13日起用~(60)钴第二次足量放疗,鼻咽复发癌灶TD6500拉得/60天。又17个月后,79年12月3日门诊复查,鼻咽右侧壁癌灶向下侵及口咽右侧壁,用“OC”(即环磷酰胺和长春新碱)方案化疗。可是患者自作主张,又购买羟基脲2并,每天三次,每次二粒,从12月4日起到12月25日止计22天,共服132粒羟基脲。在此期间,于16
Patient Luo Mou, male, 56 years old, hospital number 35495. Biopsy confirmed poorly differentiated squamous cell carcinoma of the nasopharyngeal, T_2N_1M_0 belongs to phase II, and began to use standard cobalt (60) cobalt radiation therapy on November 7, 74. After 41 months, another biopsy confirmed the recurrence of nasopharyngeal foci, and on July 13, 78, a second dose of ~(60) cobalt was used for radiotherapy. The nasopharyngeal recurrent cancer TD6500 was pulled/60 days. After another 17 months, the clinic was reviewed on December 3, 2007. The right side wall of the nasopharyngeal infiltrated the right side of the oropharynx, and was treated with “OC” (ie, cyclophosphamide and vincristine) chemotherapy. However, the patient made his own claim and bought hydroxyurea 2 twice a day three times, each time, from December 4 to December 25 for a total of 22 days, serving a total of 132 hydroxyurea. During this period, at 16